Azenta Debt to Equity Ratio 2011-2025 | AZTA
Current and historical debt to equity ratio values for Azenta (AZTA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Azenta debt/equity for the three months ending June 30, 2025 was 0.00.
| Azenta Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $0.35B | $1.67B | 0.21 |
| 2025-03-31 | $0.34B | $1.70B | 0.20 |
| 2024-12-31 | $0.32B | $1.72B | 0.19 |
| 2024-09-30 | $0.33B | $1.77B | 0.19 |
| 2024-06-30 | $0.33B | $1.99B | 0.17 |
| 2024-03-31 | $0.34B | $2.22B | 0.15 |
| 2023-12-31 | $0.38B | $2.44B | 0.16 |
| 2023-09-30 | $0.35B | $2.54B | 0.14 |
| 2023-06-30 | $0.35B | $2.72B | 0.13 |
| 2023-03-31 | $0.36B | $2.90B | 0.12 |
| 2022-12-31 | $0.42B | $2.87B | 0.15 |
| 2022-09-30 | $0.35B | $3.36B | 0.11 |
| 2022-06-30 | $0.30B | $3.43B | 0.09 |
| 2022-03-31 | $0.69B | $3.47B | 0.20 |
| 2021-12-31 | $0.49B | $1.37B | 0.36 |
| 2021-09-30 | $0.49B | $1.33B | 0.37 |
| 2021-06-30 | $0.46B | $1.31B | 0.35 |
| 2021-03-31 | $0.40B | $1.27B | 0.31 |
| 2020-12-31 | $0.36B | $1.25B | 0.29 |
| 2020-09-30 | $0.35B | $1.21B | 0.29 |
| 2020-06-30 | $0.33B | $1.18B | 0.28 |
| 2020-03-31 | $0.32B | $1.16B | 0.27 |
| 2019-12-31 | $0.40B | $1.16B | 0.35 |
| 2019-09-30 | $0.38B | $1.14B | 0.33 |
| 2019-06-30 | $0.76B | $0.74B | 1.02 |
| 2019-03-31 | $0.76B | $0.73B | 1.04 |
| 2018-12-31 | $0.77B | $0.73B | 1.05 |
| 2018-09-30 | $0.38B | $0.72B | 0.53 |
| 2018-06-30 | $0.38B | $0.71B | 0.53 |
| 2018-03-31 | $0.37B | $0.70B | 0.53 |
| 2017-12-31 | $0.36B | $0.63B | 0.58 |
| 2017-09-30 | $0.16B | $0.61B | 0.26 |
| 2017-06-30 | $0.16B | $0.59B | 0.27 |
| 2017-03-31 | $0.15B | $0.57B | 0.27 |
| 2016-12-31 | $0.14B | $0.55B | 0.25 |
| 2016-09-30 | $0.13B | $0.55B | 0.24 |
| 2016-06-30 | $0.14B | $0.54B | 0.26 |
| 2016-03-31 | $0.15B | $0.54B | 0.27 |
| 2015-12-31 | $0.13B | $0.62B | 0.21 |
| 2015-09-30 | $0.13B | $0.63B | 0.20 |
| 2015-06-30 | $0.14B | $0.63B | 0.22 |
| 2015-03-31 | $0.13B | $0.63B | 0.20 |
| 2014-12-31 | $0.13B | $0.63B | 0.20 |
| 2014-09-30 | $0.14B | $0.64B | 0.21 |
| 2014-06-30 | $0.14B | $0.66B | 0.21 |
| 2014-03-31 | $0.13B | $0.63B | 0.21 |
| 2013-12-31 | $0.10B | $0.63B | 0.15 |
| 2013-09-30 | $0.10B | $0.63B | 0.17 |
| 2013-06-30 | $0.10B | $0.62B | 0.16 |
| 2013-03-31 | $0.09B | $0.63B | 0.15 |
| 2012-12-31 | $0.09B | $0.64B | 0.14 |
| 2012-09-30 | $0.09B | $0.65B | 0.14 |
| 2012-06-30 | $0.12B | $0.53B | 0.23 |
| 2012-03-31 | $0.11B | $0.52B | 0.22 |
| 2011-12-31 | $0.11B | $0.52B | 0.21 |
| 2011-09-30 | $0.12B | $0.52B | 0.23 |
| 2011-06-30 | $0.11B | $0.51B | 0.22 |
| 2011-03-31 | $0.12B | $0.44B | 0.27 |
| 2010-12-31 | $0.12B | $0.41B | 0.30 |
| 2010-09-30 | $0.13B | $0.39B | 0.33 |
| 2010-06-30 | $0.14B | $0.36B | 0.38 |
| 2010-03-31 | $0.13B | $0.34B | 0.38 |
| 2009-12-31 | $0.11B | $0.32B | 0.34 |
| 2009-09-30 | $0.09B | $0.32B | 0.29 |
| 2009-06-30 | $0.09B | $0.33B | 0.26 |
| 2009-03-31 | $0.09B | $0.36B | 0.24 |
| 2008-12-31 | $0.10B | $0.51B | 0.20 |
| 2008-09-30 | $0.12B | $0.54B | 0.22 |
| 2008-06-30 | $0.13B | $0.76B | 0.16 |
| 2008-03-31 | $0.14B | $0.77B | 0.18 |
| 2007-12-31 | $0.13B | $0.83B | 0.15 |
| 2007-09-30 | $0.16B | $0.86B | 0.18 |
| 2007-06-30 | $0.15B | $0.97B | 0.16 |
| 2007-03-31 | $0.16B | $0.94B | 0.17 |
| 2006-12-31 | $0.18B | $0.83B | 0.21 |
| 2006-09-30 | $0.19B | $0.80B | 0.24 |
| 2006-06-30 | $0.35B | $0.78B | 0.45 |
| 2006-03-31 | $0.35B | $0.76B | 0.46 |
| 2005-12-31 | $0.33B | $0.75B | 0.45 |
| 2005-09-30 | $0.31B | $0.31B | 1.01 |
| 2005-06-30 | $0.32B | $0.32B | 1.03 |
| 2005-03-31 | $0.33B | $0.32B | 1.05 |
| 2004-12-31 | $0.33B | $0.32B | 1.05 |
| 2004-09-30 | $0.36B | $0.31B | 1.15 |
| 2004-06-30 | $0.36B | $0.30B | 1.17 |
| 2004-03-31 | $0.36B | $0.29B | 1.23 |
| 2003-12-31 | $0.33B | $0.28B | 1.17 |
| 2003-09-30 | $0.33B | $0.16B | 2.03 |
| 2003-06-30 | $0.34B | $0.21B | 1.66 |
| 2003-03-31 | $0.34B | $0.23B | 1.47 |
| 2002-12-31 | $0.35B | $0.25B | 1.39 |
| 2002-09-30 | $0.35B | $0.31B | 1.13 |
| 2002-06-30 | $0.43B | $0.94B | 0.45 |
| 2002-03-31 | $0.28B | $0.44B | 0.64 |
| 2001-12-31 | $0.29B | $0.44B | 0.65 |
| 2001-09-30 | $0.29B | $0.42B | 0.67 |
| 2001-06-30 | $0.29B | $0.45B | 0.65 |
| 2001-03-31 | $0.11B | $0.42B | 0.25 |
| 2000-12-31 | $0.11B | $0.42B | 0.25 |
| 2000-09-30 | $0.10B | $0.42B | 0.24 |
| 2000-06-30 | $0.09B | $0.40B | 0.22 |
| 2000-03-31 | $0.08B | $0.39B | 0.21 |
| 1999-12-31 | $0.04B | $0.15B | 0.27 |
| 1999-09-30 | $0.04B | $0.14B | 0.25 |
| 1999-06-30 | $0.03B | $0.12B | 0.23 |
| 1999-03-31 | $0.02B | $0.12B | 0.15 |
| 1998-12-31 | $0.02B | $0.12B | 0.13 |
| 1998-09-30 | $0.02B | $0.12B | 0.16 |
| 1998-06-30 | $0.01B | $0.13B | 0.09 |
| 1998-03-31 | $0.02B | $0.13B | 0.12 |
| 1997-12-31 | $0.00B | 0.00 | |
| 1997-09-30 | $0.02B | $0.05B | 0.34 |
| 1997-06-30 | $0.02B | $0.05B | 0.48 |
| 1997-03-31 | $0.02B | $0.05B | 0.35 |
| 1996-12-31 | $0.01B | $0.05B | 0.26 |
| 1996-09-30 | $0.01B | $0.05B | 0.28 |
| 1996-06-30 | $0.02B | $0.05B | 0.31 |
| 1996-03-31 | $0.01B | $0.05B | 0.30 |
| 1995-12-31 | $0.01B | $0.04B | 0.31 |
| 1995-09-30 | $0.01B | $0.04B | 0.25 |
| 1995-06-30 | $0.01B | $0.02B | 0.43 |
| 1995-03-31 | $0.01B | $0.02B | 0.37 |
| 1994-12-31 | $0.00B | 0.00 | |
| 1994-09-30 | $0.01B | $0.00B | 1.87 |
| 1994-06-30 | $0.00B | 0.00 | |
| 1994-03-31 | $0.00B | 0.00 | |
| 1993-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.400B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| Hims & Hers Health (HIMS) | United States | $9.884B | 76.72 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |